Slow The Burn Part 2: A Deeper Dive On How To Mitigate Financial Risk Before Selecting An Outsourcing Vendor

In this webinar, the following speakers delve into the crucial aspects of selecting an outsourcing partner for your clinical program:

• Raul P. Lima, Executive Vice President of Clinical Operations, inSeption Group
• Audrey Rossow, Senior Director of Clinical Operations, Alzheon
• Steven Zelenkofske, D.O. ,M.S., FACC, FCCP, FACOI, Principal Consultant/Board Director/CSO
  SLZ Consulting LLC/Dinaqor AG and Cadrenal Therapeutics/Dinaqor AG
• Kenneth Getz, Executive Director and Research Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

In part two of this webinar series (watch part one here), the group focuses on avoiding potential risks such as unexpected budget changes and unplanned change orders that could jeopardize the success of your trial. Drawing insights from previous discussions with clinical operations experts, the presenters emphasize the significance of a meticulous contract review during the partner selection process.

Watch the video below to explore common red flags, ask critical questions, and adopt best practices to safeguard your trial's budget. By the end of this presentation, viewers will be equipped with the knowledge to prepare for the financial responsibilities of clinical trials, understand the necessity for flexibility and creativity in a CRO contract, identify signs of contracts favoring the CRO's bottom line to the detriment of trial integrity, appreciate the role of AI in bid evaluation, and assert control over clinical studies by clearly outlining expectations.